GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                            
                            
                            
                                 Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Compound 3 is the lead for a novel series of antimalarial compounds based on a benzimidazole core [1].  
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Guide to Malaria Pharmacology Comments | 
| A phenotypic high-throughput screen of the Novartis chemical library, followed by a hit to lead effort, identified compound 3 as an early lead with promising antimalarial activity [1]. SAR analysis was carried out but further optimization will be necessary to improve pharmacokinetic properties and address potential cardiotoxicity issues. Potential Target/Mechanism Of Action: As the precise mechanism of action of compound 3 is not yet known, we do not have a molecular target for this compound.  |